Allworth Financial’s ClearPoint Neuro CLPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.23K Buy
101
+27
+36% +$405 ﹤0.01% 4900
2026
Q2
$1.32K Buy
74
+5
+7% +$62 ﹤0.01% 4649
2026
Q1
$628 Buy
69
+4
+6% +$51 ﹤0.01% 4688
2025
Q4
$890 Sell
65
-2,000
-97% -$37.1K ﹤0.01% 4392
2025
Q3
$45K Hold
2,065
– – ﹤0.01% 2168
2025
Q2
$24.7K Buy
2,065
+2,000
+3,077% +$25.2K ﹤0.01% 2394
2025
Q1
$929 Hold
65
– – ﹤0.01% 3494
2024
Q4
$1.16K Hold
65
– – ﹤0.01% 3343
2024
Q3
$729 Hold
65
– – ﹤0.01% 3331
2024
Q2
$460 Hold
65
– – ﹤0.01% 3392
2024
Q1
$442 Hold
65
– – ﹤0.01% 3313
2023
Q4
$442 Hold
65
– – ﹤0.01% 3162
2023
Q3
$326 Hold
65
– – ﹤0.01% 3149
2023
Q2
$471 Hold
65
– – ﹤0.01% 2911
2023
Q1
$549 Hold
65
– – ﹤0.01% 2823
2022
Q4
$551 Hold
65
– – ﹤0.01% 2610
2022
Q3
$1K Buy
+65
New +$857 ﹤0.01% 2340

Other funds holding CLPT

Allworth Financial's CLPT Position: Q3 2026 in Review

Allworth Financial increased its ClearPoint Neuro (CLPT) stake by 36% in Q3 2026, buying an estimated $405 and bringing the position to 101 shares worth $1.23K. The position accounts for ﹤0.01% of the portfolio, ranked #4900.

Allworth Financial first reported a position in CLPT in Q3 2022 and has held it in 17 quarters since. The position peaked at $45K in Q3 2025. 126 funds tracked by Wall St. Rank hold CLPT as of Q3 2026.

  • Allworth Financial held 101 shares of ClearPoint Neuro worth $1.23K as of Q3 2026.
  • Allworth Financial bought 27 ClearPoint Neuro shares in Q3 2026, an estimated $405.
  • ClearPoint Neuro made up ﹤0.01% of Allworth Financial's portfolio in Q3 2026, its #4900 holding.
  • Allworth Financial first reported a position in ClearPoint Neuro in Q3 2022 and has held it in 17 quarters since.
  • Allworth Financial's ClearPoint Neuro position peaked at $45K in Q3 2025.
  • 126 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q3 2026.

Based on Allworth Financial's 13F filing for Q3 2026, filed 6 Nov 2026.